Farallon Capital Partners L.P. 13D and 13G filings for Protagonist Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-02 09:19 am Purchase | 2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | Farallon Capital Partners L.P. | 5,765,109 9.990% | 710,007 (+14.05%) | Filing |
| 2023-02-09 4:54 pm Purchase | 2022-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | Farallon Capital Partners L.P. | 5,055,102 9.990% | 5,055,102 (New Position) | Filing |